Bravo MD2Trader. I appreciate your post. You obviously have a trader's perspective and a scientific/medical perspective. You see that Aviptadil is the real deal, and have committed to see the investment to its fruition. Tell me, did it surprise you as well that 19 of 21 consecutive critical Covid-19 cases were successfully treated? Patients that were so dire they couldn't even get into the critical trial. Excluded based on their horrible condition. Yet, the compassionate use extension took all comers, without picking and choosing, and healed them one after another.
Consecutive. It still amazes me.
This therapeutic, RLF-100/Aviptadil/SamiVir, is the key to ending deaths from Covid-19. For starters.